These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 16145001

  • 1. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent.
    Sirol M, Fuster V, Badimon JJ, Fallon JT, Moreno PR, Toussaint JF, Fayad ZA.
    Circulation; 2005 Sep 13; 112(11):1594-600. PubMed ID: 16145001
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent.
    Spuentrup E, Katoh M, Buecker A, Fausten B, Wiethoff AJ, Wildberger JE, Haage P, Parsons EC, Botnar RM, Graham PB, Vettelschoss M, Günther RW.
    Invest Radiol; 2007 Aug 13; 42(8):586-95. PubMed ID: 17620942
    [Abstract] [Full Text] [Related]

  • 7. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z, Liu SY, Xiao XS, Zhong GR, Jiang QJ.
    Zhonghua Yi Xue Za Zhi; 2007 Mar 13; 87(10):673-8. PubMed ID: 17553304
    [Abstract] [Full Text] [Related]

  • 8. Molecular magnetic resonance imaging of deep vein thrombosis using a fibrin-targeted contrast agent: a feasibility study.
    Katoh M, Haage P, Wiethoff AJ, Günther RW, Bücker A, Tacke J, Spuentrup E.
    Invest Radiol; 2009 Mar 13; 44(3):146-50. PubMed ID: 19151606
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent.
    Botnar RM, Perez AS, Witte S, Wiethoff AJ, Laredo J, Hamilton J, Quist W, Parsons EC, Vaidya A, Kolodziej A, Barrett JA, Graham PB, Weisskoff RM, Manning WJ, Johnstone MT.
    Circulation; 2004 Apr 27; 109(16):2023-9. PubMed ID: 15066940
    [Abstract] [Full Text] [Related]

  • 13. Magnetic resonance contrast enhancement with gadolinium-DTPA in patients with angina and angiographically normal coronary arteries: effect of chronic beta-blockade.
    Rossetti E, Fragasso G, Mellone R, Vanzulli A, Del Maschio A, Chierchia SL.
    Cardiologia; 1999 Jul 27; 44(7):653-9. PubMed ID: 10476591
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
    Guo YM, Liu M, Yang JL, Guo XJ, Wang SC, Duan XY, Wang P.
    Chin Med J (Engl); 2007 Jan 05; 120(1):50-5. PubMed ID: 17254488
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High-dose Gd-DTPA vs. Bis-Gd-mesoporphyrin for monitoring laser-induced tissue necrosis.
    Bremer C, Bankert J, Filler T, Ebert W, Tombach B, Reimer P.
    J Magn Reson Imaging; 2005 Jun 05; 21(6):801-8. PubMed ID: 15906334
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.